Publikationsserver der Universitätsbibliothek Marburg
Titel:Identification and characterization of host specificity factors of a lethal human influenza H5N1 isolate
Autor:Mänz, Benjamin
Weitere Beteiligte: Klenk, Hans-Dieter (Professor)
Veröffentlicht:2012
URI:https://archiv.ub.uni-marburg.de/diss/z2012/0856
URN: urn:nbn:de:hebis:04-z2012-08565
DOI: https://doi.org/10.17192/z2012.0856
DDC: Medizin
Titel (trans.):Identifikation und Charakterisierung von Faktoren der Wirtsspezifität eines Influenza H5N1 Isolates einer letalen humanen Infektion
Publikationsdatum:2012-09-24
Lizenz:https://rightsstatements.org/vocab/InC-NC/1.0/

Dokument

Schlagwörter:
H5N1, pathogenicity, Influenza, Influenzaviren, Anpassung, Influenza-A-Virus, adaptation, Wirtsspezifität, Vogelgrippe, Grippe, human

Summary:
Influenza A viruses are major human and avian pathogens. Despite a species barrier, subtypes of influenza A can transmit from the avian reservoir to humans and widely spread in the population. Since H5N1 viruses circulate in the avian reservoir and cause high lethality rates when transmitted to humans, infections with the H5N1 subtype pose an ongoing threat. Although human-to-human transmission is a rare event, rapid evolution of the virus might result in a strain, which gains the ability to spread in the human population, leading to high morbidity and mortality. Advanced surveillance by understanding the mechanisms by which influenza viruses acquire the ability to cross the species barrier from birds to humans and new strategies to improve current vaccines are needed to control future pandemics. In this study, the fatal human case isolate A/Thailand/1(KAN-1)/2004 (H5N1) (KAN-1) was analyzed to examine mechanisms of H5N1 viruses to overcome host range restriction. • We were able to identify an adaptive mutation in KAN-1 hemagglutinin (HA). A polymorphism leading to an amino acid change in the HA that was previously reported to be positively selected during replication in humans altered the organ tropism of KAN- 1 in mice and ferrets. In the mouse model we found an increased replication of the selected variant in the lung. • In a genetic analysis of the KAN-1 virus, we identified further mutations crucial for adaptation to the mammalian host. Interestingly, the KAN-1 polymerase was poorly adapted to human cells, in contrast to other H5N1 viruses isolated from humans. We identified the NEP protein as a new pathogenicity factor of H5N1 viruses in humans, which is able to overcome this incomplete adaptation of the KAN-1 and avian H5N1 polymerases in human cells. Furthermore, functional studies revealed that the restriction of avian influenza polymerases in mammals is due to a general defect in RNA-replication and not transcription. • Since the human MxA GTPase is an important factor in the immune response against influenza viruses, we analyzed its antiviral activity against KAN-1. KAN-1 proved to be sensitive, while an isolate of the 2009 pandemic was relatively resistant to MxA. We were able to determine the viral nucleoprotein (NP) as the determinant for MxA sensitivity in vitro and in vivo. In addition, we identified mutations in NP responsible for resistance against MxA and could draw conclusions about the evolution of NP. • Based on our knowledge about protein-protein interactions in the polymerase complex, we developed a new strategy to create polymerase assembly mutants as a basis for live attenuated vaccines against H5N1. Vaccination of mice with these mutants showed protection against homologous and heterologous challenge with lethal doses of H5N1 viruses including KAN-1, therefore providing new options for live attenuated vaccine design.

Bibliographie / References

  1. Zhou, N. N., K. F. Shortridge, E. C. Claas, S. L. Krauss, and R. G. Webster. 1999. Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong. Journal of virology 73:3366-3374.
  2. Fouchier, R. A., V. Munster, A. Wallensten, T. M. Bestebroer, S. Herfst, D. Smith, G. F. Rimmelzwaan, B. Olsen, and A. D. Osterhaus. 2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. Journal of virology 79:2814-2822.
  3. Webster, R. G., M. Yakhno, V. S. Hinshaw, W. J. Bean, and K. G. Murti. 1978. Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology 84:268-278.
  4. Mehle, A., and J. A. Doudna. 2008. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 4:111-122.
  5. Garten, W., and H. D. Klenk. 1999. Understanding influenza virus pathogenicity. Trends Microbiol 7:99-100.
  6. Yuan, P., M. Bartlam, Z. Lou, S. Chen, J. Zhou, X. He, Z. Lv, R. Ge, X. Li, T. Deng, E. Fodor, Z. Rao, and Y. Liu. 2009. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 458:909-913.
  7. Gabriel, G., B. Dauber, T. Wolff, O. Planz, H. D. Klenk, and J. Stech. 2005. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A 102:18590-18595.
  8. Puzelli, S., L. Di Trani, C. Fabiani, L. Campitelli, M. A. De Marco, I. Capua, J. F. Aguilera, M. Zambon, and I. Donatelli. 2005. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2003. J Infect Dis 192:1318-1322.
  9. Stech, J. 2008. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines. Expert Rev Vaccines 7:739-743.
  10. Robb, N. C., M. Smith, F. T. Vreede, and E. Fodor. 2009. NS2/NEP protein regulates transcription and replication of the influenza virus RNA genome. J Gen Virol 90:1398-1407.
  11. Moncorge, O., M. Mura, and W. S. Barclay. 2010. Evidence for avian and human host cell factors that affect the activity of influenza virus polymerase. Journal of virology 84:9978-9986.
  12. Li, Z., H. Chen, P. Jiao, G. Deng, G. Tian, Y. Li, E. Hoffmann, R. G. Webster, Y. Matsuoka, and K. Yu. 2005. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. Journal of virology 79:12058- 12064.
  13. Scheiffele, P., A. Rietveld, T. Wilk, and K. Simons. 1999. Influenza viruses select ordered lipid domains during budding from the plasma membrane. The Journal of biological chemistry 274:2038-2044.
  14. Zhang, J., A. Pekosz, and R. A. Lamb. 2000. Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. Journal of virology 74:4634-4644.
  15. Mänz, B., M. Matrosovich, N. Bovin, and M. Schwemmle. 2010. A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice. Journal of virology 84:8316-8321.
  16. Klenk, H. D., R. Rott, M. Orlich, and J. Blodorn. 1975. Activation of influenza A viruses by trypsin treatment. Virology 68:426-439. 74. Kongchanagul, A., O. Suptawiwat, P. Kanrai, M. Uiprasertkul, P. Puthavathana, and P. Auewarakul. 2008. Positive selection at the receptor- binding site of haemagglutinin H5 in viral sequences derived from human tissues. J Gen Virol 89:1805-1810.
  17. Maassab, H. F. 1967. Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature 213:612-614.
  18. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, and N. Cox. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396.
  19. Palese, P., K. Tobita, M. Ueda, and R. W. Compans. 1974. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397-410.
  20. Li, X., and P. Palese. 1994. Characterization of the polyadenylation signal of influenza virus RNA. Journal of virology 68:1245-1249.
  21. Nieto, A., S. de la Luna, J. Barcena, A. Portela, and J. Ortin. 1994. Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit. J Gen Virol 75 ( Pt 1):29-36.
  22. Wharton, S. A., R. W. Ruigrok, S. R. Martin, J. J. Skehel, P. M. Bayley, W. Weis, and D. C. Wiley. 1988. Conformational aspects of the acid-induced fusion mechanism of influenza virus hemagglutinin. Circular dichroism and fluorescence studies. The Journal of biological chemistry 263:4474-4480.
  23. Webster, R. G., and W. G. Laver. 1980. Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance. Virology 104:139-148.
  24. Ponten, A., C. Sick, M. Weeber, O. Haller, and G. Kochs. 1997. Dominant- negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. Journal of virology 71:2591-2599.
  25. Portela. 1999. Efficient formation of influenza virus-like particles: dependence on the expression levels of viral proteins. J Gen Virol 80 ( Pt 7):1635-1645.
  26. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-179.
  27. Ward, A. C., L. A. Castelli, A. C. Lucantoni, J. F. White, A. A. Azad, and I. G. Macreadie. 1995. Expression and analysis of the NS2 protein of influenza A virus. Arch Virol 140:2067-2073.
  28. Haller, O., and G. Kochs. 2011. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31:79-87.
  29. Simonsen, L., T. A. Reichert, C. Viboud, W. C. Blackwelder, R. J. Taylor, and M. A. Miller. 2005. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165:265-272.
  30. Umbach, J. L., H. L. Yen, L. L. Poon, and B. R. Cullen. 2010. Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. MBio 1.
  31. Skehel, J. J., and D. C. Wiley. 1995. Influenza viruses and cell membranes. Am J Respir Crit Care Med 152:S13-15.
  32. Pinto, L. H., L. J. Holsinger, and R. A. Lamb. 1992. Influenza virus M2 protein has ion channel activity. Cell 69:517-528.
  33. Lamb, R. A., S. L. Zebedee, and C. D. Richardson. 1985. Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40:627-633.
  34. Shapiro, G. I., and R. M. Krug. 1988. Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. Journal of virology 62:2285-2290.
  35. Takeuchi, O., and S. Akira. 2009. Innate immunity to virus infection. Immunol Rev 227:75-86.
  36. Gabriel, G., A. Herwig, and H. D. Klenk. 2008. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog 4:e11. 40. Gabriel, G., K. Klingel, A. Otte, S. Thiele, B. Hudjetz, G. Arman-Kalcek, M. Sauter, T. Shmidt, F. Rother, S. Baumgarte, B. Keiner, E. Hartmann, M. Bader, G. G. Brownlee, E. Fodor, and H. D. Klenk. 2011. Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun 2:156.
  37. Newcomb, L. L., R. L. Kuo, Q. Ye, Y. Jiang, Y. J. Tao, and R. M. Krug. 2009. Interaction of the influenza a virus nucleocapsid protein with the viral RNA polymerase potentiates unprimed viral RNA replication. Journal of virology 83:29-36.
  38. Palm, M., M. M. Garigliany, F. Cornet, and D. Desmecht. 2010. Interferon- induced Sus scrofa Mx1 blocks endocytic traffic of incoming influenza A virus particles. Vet Res 41:29.
  39. Muller, M., H. Ibelgaufts, and I. M. Kerr. 1994. Interferon response pathways-- a paradigm for cytokine signalling? J Viral Hepat 1:87-103.
  40. Obenauer, J. C., J. Denson, P. K. Mehta, X. Su, S. Mukatira, D. B. Finkelstein, X. Xu, J. Wang, J. Ma, Y. Fan, K. M. Rakestraw, R. G. Webster, E. Hoffmann, S. Krauss, J. Zheng, Z. Zhang, and C. W. Naeve. 2006. Large- scale sequence analysis of avian influenza isolates. Science 311:1576-1580. 111. Pal, S., A. Santos, J. M. Rosas, J. Ortiz-Guzman, and G. Rosas-Acosta. 2011. Influenza A virus interacts extensively with the cellular SUMOylation system during infection. Virus Res 158:12-27.
  41. Vreede, F. T., T. E. Jung, and G. G. Brownlee. 2004. Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates. Journal of virology 78:9568-9572.
  42. Hatta, M., P. Gao, P. Halfmann, and Y. Kawaoka. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840- 1842.
  43. Puthavathana, P., P. Auewarakul, P. C. Charoenying, K. Sangsiriwut, P. Pooruk, K. Boonnak, R. Khanyok, P. Thawachsupa, R. Kijphati, and P. Sawanpanyalert. 2005. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J Gen Virol 86:423-433.
  44. Morozumi, T., T. Naito, P. D. Lan, E. Nakajima, T. Mitsuhashi, S. Mikawa, T. Hayashi, T. Awata, H. Uenishi, K. Nagata, T. Watanabe, and N. Hamasima. 2009. Molecular cloning and characterization of porcine Mx2 gene. Mol Immunol 46:858-865.
  45. Salomon, R., P. Staeheli, G. Kochs, H. L. Yen, J. Franks, J. E. Rehg, R. G. Webster, and E. Hoffmann. 2007. Mx1 gene protects mice against the highly lethal human H5N1 influenza virus. Cell Cycle 6:2417-2421.
  46. Staeheli, P., O. Haller, W. Boll, J. Lindenmann, and C. Weissmann. 1986. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147-158.
  47. Richardson, J. C., and R. K. Akkina. 1991. NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells. Arch Virol 116:69- 80.
  48. Neumann, G., M. R. Castrucci, and Y. Kawaoka. 1997. Nuclear import and export of influenza virus nucleoprotein. Journal of virology 71:9690-9700.
  49. Whittaker, G., M. Bui, and A. Helenius. 1996. Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons. Journal of virology 70:2743-2756.
  50. Martin, K., and A. Helenius. 1991. Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117-130.
  51. Siegl, G., J. Pette, and H. Mahnel. 1968. [On the structure of equine influenza virus. A contribution on the ultrastructure of influenza viruses]. Arch Gesamte Virusforsch 24:299-311.
  52. Smith, G. J., D. Vijaykrishna, J. Bahl, S. J. Lycett, M. Worobey, O. G. Pybus, S. K. Ma, C. L. Cheung, J. Raghwani, S. Bhatt, J. S. Peiris, Y. Guan, and A. Rambaut. 2009. Origins and evolutionary genomics of the 2009 swine- origin H1N1 influenza A epidemic. Nature 459:1122-1125.
  53. Sugrue, R. J., R. B. Belshe, and A. J. Hay. 1990. Palmitoylation of the influenza A virus M2 protein. Virology 179:51-56.
  54. Perkins, L. E., and D. E. Swayne. 2002. Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks, and pigeons. Avian Dis 46:53-63.
  55. Polymerase Assembly Mutants experiment of nature. J Infect Dis 193:49-53.
  56. Ito, T., Y. Kawaoka, A. Nomura, and K. Otsuki. 1999. Receptor specificity of influenza A viruses from sea mammals correlates with lung sialyloligosaccharides in these animals. J Vet Med Sci 61:955-958.
  57. Grimm, D., P. Staeheli, M. Hufbauer, I. Koerner, L. Martinez-Sobrido, A. Solorzano, A. Garcia-Sastre, O. Haller, and G. Kochs. 2007. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci U S A 104:6806-6811. 50. Guilligay, D., F. Tarendeau, P. Resa-Infante, R. Coloma, T. Crepin, P. Sehr, J. Lewis, R. W. Ruigrok, J. Ortin, D. J. Hart, and S. Cusack. 2008. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat Struct Mol Biol 15:500-506.
  58. Massin, P., S. van der Werf, and N. Naffakh. 2001. Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. Journal of virology 75:5398-5404. 90. Matrosovich, M., N. Zhou, Y. Kawaoka, and R. Webster. 1999. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. Journal of virology 73:1146-1155. 91. Matrosovich, M. N., A. S. Gambaryan, S. Teneberg, V. E. Piskarev, S. S. Yamnikova, D. K. Lvov, J. S. Robertson, and K. A. Karlsson. 1997. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 233:224-234. 92. Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H. D.
  59. Tumpey, T. M., and J. A. Belser. 2009. Resurrected pandemic influenza viruses. Annu Rev Microbiol 63:79-98.
  60. Honda, A., K. Ueda, K. Nagata, and A. Ishihama. 1988. RNA polymerase of influenza virus: role of NP in RNA chain elongation. J Biochem 104:1021-1026. 61. Horimoto, T., and Y. Kawaoka. 2001. Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 14:129-149.
  61. Ulmanen, I., B. A. Broni, and R. M. Krug. 1981. Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc Natl Acad Sci U S A 78:7355-7359.
  62. Rogers, G. N., J. C. Paulson, R. S. Daniels, J. J. Skehel, I. A. Wilson, and D. C. Wiley. 1983. Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity. Nature 304:76-78.
  63. Ng, A. K., H. Zhang, K. Tan, Z. Li, J. H. Liu, P. K. Chan, S. M. Li, W. Y. Chan, S. W. Au, A. Joachimiak, T. Walz, J. H. Wang, and P. C. Shaw. 2008. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. Faseb J 22:3638-3647.
  64. Lamb, R. A., and P. W. Choppin. 1983. The gene structure and replication of influenza virus. Annu Rev Biochem 52:467-506.
  65. Resa-Infante, P., N. Jorba, N. Zamarreno, Y. Fernandez, S. Juarez, and J. Ortin. 2008. The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication. PloS one 3:e3904.
  66. Fernandez-Sesma, A. 2007. The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Infect Disord Drug Targets 7:336-343.
  67. Varga, Z. T., I. Ramos, R. Hai, M. Schmolke, A. Garcia-Sastre, A. Fernandez-Sesma, and P. Palese. 2011. The influenza virus protein PB1-F2 inhibits the induction of type i interferon at the level of the MAVS adaptor protein. PLoS Pathog 7:e1002067.
  68. Haller, O., S. Stertz, and G. Kochs. 2007. The Mx GTPase family of interferon- induced antiviral proteins. Microbes Infect 9:1636-1643.
  69. The N-terminal region of the PA subunit of the RNA polymerase of influenza A/HongKong/156/97 (H5N1) influences promoter binding. PloS one 4:e5473. 68.
  70. Hulse-Post, J. Humberd, M. Trichet, J. E. Rehg, R. J. Webby, R. G. Webster, and E. Hoffmann. 2006. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med 203:689-697.
  71. Whittaker, G., M. Bui, and A. Helenius. 1996. The role of nuclear import and export in influenza virus infection. Trends Cell Biol 6:67-71.
  72. Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25:373-381.
  73. Johnson, N. P., and J. Mueller. 2002. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 76:105-115. 67. Kashiwagi, T., B. W. Leung, T. Deng, H. Chen, and G. G. Brownlee. 2009.
  74. Staeheli, P., R. Grob, E. Meier, J. G. Sutcliffe, and O. Haller. 1988. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 8:4518-4523.
  75. Lindenmann, J. 1962. Resistance of mice to mouse-adapted influenza A virus. Virology 16:203-204.
  76. Lindenmann, J. 1964. Inheritance of Resistance to Influenza Virus in Mice. Proc Soc Exp Biol Med 116:506-509.
  77. Wong, K. K., R. A. Bull, S. Rockman, G. Scott, S. Stelzer-Braid, and W. Rawlinson. 2011. Correlation of polymerase replication fidelity with genetic evolution of influenza A/Fujian/411/02(H3N2) viruses. J Med Virol 83:510-516.
  78. Wagner, R., M. Matrosovich, and H. D. Klenk. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 12:159-166.
  79. Haller, O., and G. Kochs. 2002. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3:710-717.
  80. Palm, M., M. Leroy, A. Thomas, A. Linden, and D. Desmecht. 2007. Differential anti-influenza activity among allelic variants at the Sus scrofa Mx1 locus. J Interferon Cytokine Res 27:147-155.
  81. Mordstein, M., G. Kochs, L. Dumoutier, J. C. Renauld, S. R. Paludan, K. Klucher, and P. Staeheli. 2008. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog 4:e1000151.
  82. Skehel, J. J., and D. C. Wiley. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531-569.
  83. Melen, K., L. Kinnunen, R. Fagerlund, N. Ikonen, K. Y. Twu, R. M. Krug, and I. Julkunen. 2007. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. Journal of virology 81:5995-6006.
  84. Gomez-Puertas, P., C. Albo, E. Perez-Pastrana, A. Vivo, and A. Portela. 2000. Influenza virus matrix protein is the major driving force in virus budding. Journal of virology 74:11538-11547.
  85. Goto, H., K. Wells, A. Takada, and Y. Kawaoka. 2001. Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus. Journal of virology 75:9297-9301.
  86. O'Neill, R. E., J. Talon, and P. Palese. 1998. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. Embo J 17:288- 296.
  87. Maines, T. R., X. H. Lu, S. M. Erb, L. Edwards, J. Guarner, P. W. Greer, D. C. Nguyen, K. J. Szretter, L. M. Chen, P. Thawatsupha, M. Chittaganpitch, S. Waicharoen, D. T. Nguyen, T. Nguyen, H. H. Nguyen, J. H. Kim, L. T. Hoang, C. Kang, L. S. Phuong, W. Lim, S. Zaki, R. O. Donis, N. J. Cox, J. M. Katz, and T. M. Tumpey. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. Journal of virology 79:11788-11800. Bibliography 94
  88. Fujii, Y., H. Goto, T. Watanabe, T. Yoshida, and Y. Kawaoka. 2003. Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A 100:2002-2007.
  89. Park, C. J., S. H. Bae, M. K. Lee, G. Varani, and B. S. Choi. 2003. Solution structure of the influenza A virus cRNA promoter: implications for differential recognition of viral promoter structures by RNA-dependent RNA polymerase. Nucleic Acids Res 31:2824-2832.
  90. Lin, Y. P., M. Shaw, V. Gregory, K. Cameron, W. Lim, A. Klimov, K. Subbarao, Y. Guan, S. Krauss, K. Shortridge, R. Webster, N. Cox, and A. Hay. 2000. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A 97:9654-9658.
  91. Holsinger, L. J., M. A. Shaughnessy, A. Micko, L. H. Pinto, and R. A. Lamb. 1995. Analysis of the posttranslational modifications of the influenza virus M2 protein. Journal of virology 69:1219-1225.
  92. Hatta, M., Y. Hatta, J. H. Kim, S. Watanabe, K. Shinya, T. Nguyen, P. S. Lien, Q. M. Le, and Y. Kawaoka. 2007. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog 3:1374-1379.
  93. Tumpey, T. M., K. J. Szretter, N. Van Hoeven, J. M. Katz, G. Kochs, O. Haller, A. Garcia-Sastre, and P. Staeheli. 2007. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. Journal of virology 81:10818-10821.
  94. White, J. M., and I. A. Wilson. 1987. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol 105:2887-2896.
  95. Stetson, D. B., and R. Medzhitov. 2006. Antiviral defense: interferons and beyond. J Exp Med 203:1837-1841.
  96. Goto, H., and Y. Kawaoka. 1998. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc Natl Acad Sci U S A 95:10224- 10228.
  97. Johannes, L., R. Kambadur, H. Lee-Hellmich, C. A. Hodgkinson, H. Arnheiter, and E. Meier. 1997. Antiviral determinants of rat Mx GTPases map to the carboxy-terminal half. Journal of virology 71:9792-9795.
  98. Holsinger, L. J., D. Nichani, L. H. Pinto, and R. A. Lamb. 1994. Influenza A virus M2 ion channel protein: a structure-function analysis. Journal of virology 68:1551-1563.
  99. Horimoto, T., and Y. Kawaoka. 1994. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. Journal of virology 68:3120-3128.
  100. Horimoto, T., K. Nakayama, S. P. Smeekens, and Y. Kawaoka. 1994. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. Journal of virology 68:6074- 6078.
  101. Pitossi, F., A. Blank, A. Schroder, A. Schwarz, P. Hussi, M. Schwemmle, J. Pavlovic, and P. Staeheli. 1993. A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. Journal of virology 67:6726-6732.
  102. Subbarao, E. K., W. London, and B. R. Murphy. 1993. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. Journal of virology 67:1761-1764.
  103. Kawaoka, Y., S. Krauss, and R. G. Webster. 1989. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. Journal of virology 63:4603-4608.
  104. Zebedee, S. L., and R. A. Lamb. 1988. Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. Journal of virology 62:2762-2772.
  105. Masic, A., J. S. Booth, G. K. Mutwiri, L. A. Babiuk, and Y. Zhou. 2009. Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs. Journal of virology 83:10198-10210.
  106. Wunderlich, K., D. Mayer, C. Ranadheera, A. S. Holler, B. Mänz, A. Martin, G. Chase, W. Tegge, R. Frank, U. Kessler, and M. Schwemmle. 2009. Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication. PloS one 4:e7517.
  107. Mehle, A., and J. A. Doudna. 2009. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci U S A 106:21312- 21316.
  108. Neumann, G., T. Noda, and Y. Kawaoka. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931-939.
  109. Wunderlich, K., M. Juozapaitis, B. Mänz, D. Mayer, V. Gotz, A. Zohner, T. Wolff, M. Schwemmle, and A. Martin. 2010. Limited compatibility of polymerase subunit interactions in influenza A and B viruses. The Journal of biological chemistry 285:16704-16712.
  110. Kawaoka. 2010. Role of host-specific amino acids in the pathogenicity of avian H5N1 influenza viruses in mice. J Gen Virol 91:1284-1289.
  111. Pavlovic, J., O. Haller, and P. Staeheli. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. Journal of virology 66:2564-2569.
  112. Taubenberger, J. K., and J. C. Kash. 2010. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7:440-451.
  113. Garcia-Sastre, and B. R. tenOever. 2010. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc Natl Acad Sci U S A 107:11525-11530.
  114. Graef, K. M., F. T. Vreede, Y. F. Lau, A. W. McCall, S. M. Carr, K. Subbarao, and E. Fodor. 2010. The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon. Journal of virology 84:8433-8445.
  115. Gao, R., L. Dong, J. Dong, L. Wen, Y. Zhang, H. Yu, Z. Feng, M. Chen, Y. Tan, Z. Mo, H. Liu, Y. Fan, K. Li, C. K. Li, D. Li, W. Yang, and Y. Shu. 2010. A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PloS one 5:e13315.
  116. Keiner, B., B. Mänz, R. Wagner, G. Cattoli, I. Capua, and H. D. Klenk. 2010. Intracellular distribution of NS1 correlates with the infectivity and interferon antagonism of an avian influenza virus (H7N1). Journal of virology 84:11858- 11865.
  117. Xu, K., C. Klenk, B. Liu, B. Keiner, J. Cheng, B. J. Zheng, L. Li, Q. Han, C. Wang, T. Li, Z. Chen, Y. Shu, J. Liu, H. D. Klenk, and B. Sun. 2011. Modification of nonstructural protein 1 of influenza A virus by SUMO1. Journal of virology 85:1086-1098.
  118. Mänz, B., V. Gotz, K. Wunderlich, J. Eisel, J. Kirchmair, J. Stech, O. Stech, G. Chase, R. Frank, and M. Schwemmle. 2011. Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus. The Journal of biological chemistry 286:8414-8424.
  119. O'Donnell, C. D., and K. Subbarao. 2011. The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect 13:502-515.
  120. Schusser, B., A. Reuter, A. von der Malsburg, N. Penski, S. Weigend, B. Kaspers, P. Staeheli, and S. Hartle. 2011. Mx Is Dispensable for Interferon- Mediated Resistance of Chicken Cells against Influenza A Virus. Journal of virology 85:8307-8315.
  121. Zimmermann, P., B. Mänz, O. Haller, M. Schwemmle, and G. Kochs. 2011. The viral nucleoprotein determines mx sensitivity of influenza a viruses. Journal of virology 85:8133-8140.
  122. Morens, D. M., and J. K. Taubenberger. 2011. Pandemic influenza: certain uncertainties. Rev Med Virol.
  123. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 101:1356-1361.
  124. Katze, M. G., M. Wambach, M. L. Wong, M. Garfinkel, E. Meurs, K. Chong, B. R. Williams, A. G. Hovanessian, and G. N. Barber. 1991. Functional expression and RNA binding analysis of the interferon-induced, double- stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol 11:5497-5505.
  125. Turan, K., M. Mibayashi, K. Sugiyama, S. Saito, A. Numajiri, and K. Nagata. 2004. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res 32:643-652.
  126. Klenk. 2004. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A 101:4620-4624. 93. Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H. D.
  127. Hassel, B. A., A. Zhou, C. Sotomayor, A. Maran, and R. H. Silverman. 1993. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. Embo J 12:3297-3304.
  128. Klenk. 2004. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. Journal of virology 78:12665-12667.
  129. Govorkova, E. A., J. E. Rehg, S. Krauss, H. L. Yen, Y. Guan, M. Peiris, T. D. Nguyen, T. H. Hanh, P. Puthavathana, H. T. Long, C. Buranathai, W. Lim, R. G. Webster, and E. Hoffmann. 2005. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. Journal of virology 79:2191- 2198.
  130. Varghese, J. N., J. L. McKimm-Breschkin, J. B. Caldwell, A. A. Kortt, and P. M. Colman. 1992. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor. Proteins 14:327-332.
  131. Stieneke-Grober, A., M. Vey, H. Angliker, E. Shaw, G. Thomas, C. Roberts, H. D. Klenk, and W. Garten. 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. Embo J 11:2407-2414.
  132. Samuel, C. E. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778- 809, table of contents.
  133. Skehel, J. J., P. M. Bayley, E. B. Brown, S. R. Martin, M. D. Waterfield, J. M. White, I. A. Wilson, and D. C. Wiley. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A 79:968-972.
  134. Reid, A. H., T. G. Fanning, J. V. Hultin, and J. K. Taubenberger. 1999. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 96:1651-1656.
  135. Klenk, H. D., and W. Garten. 1994. Host cell proteases controlling virus pathogenicity. Trends Microbiol 2:39-43.
  136. Yasuda, J., S. Nakada, A. Kato, T. Toyoda, and A. Ishihama. 1993. Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology 196:249-255.
  137. Taubenberger, J. K., A. H. Reid, A. E. Krafft, K. E. Bijwaard, and T. G. Fanning. 1997. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 275:1793-1796.
  138. Stevens, J., O. Blixt, T. M. Tumpey, J. K. Taubenberger, J. C. Paulson, and I. A. Wilson. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.
  139. Labadie, K., E. Dos Santos Afonso, M. A. Rameix-Welti, S. van der Werf, and N. Naffakh. 2007. Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells. Virology 362:271-282.

* Das Dokument ist im Internet frei zugänglich - Hinweise zu den Nutzungsrechten
© UB Marburg 1997 - 2024 Universitätsbibliothek Marburg